Abstract

Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive leukemia/lymphoma. The long clinical latency and low incidence of ATL indicate that ATL is an age-related disease with genetic changes that are involved in malignant transformation and monoclonal expansion of human T lymphotropic virus type 1 (HTLV-1) infected cells. The question remains as to how the ATL cells acquire monoclonal proliferation rather than undergo senescence. It was implied that aberrant cellular proteins such as p53, JAK-STAT and Bcl-xL were associated with the development of ATL. HTLV-1-infected cells and ATL cells (partial) express CD30. Soluble CD30 (sCD30) may impair the interaction of CD30 ligand+ cells with CD30+ ATL cells. Probably HTLV-1-infected T-cells migrate to the lung due to agerelated changes of pulmonary immune system. Thereafter monoclonal proliferation of infected cells following antigen presentation forms a local network between cytokines and cytokine receptors. During the remodeling of the pulmonary tissue, CD30+ ATL cells and matrix metalloproteinases can play an important role in forming tumor microenvironment. Furthermore, soluble cytokine receptors may support the clonal proliferation and invasion of ATL cells and tumor microenvironment is created in extra nodal lesions such as lung. Accordingly, sCD30 level could be applied to detection of microenvironment formation for tumor stem cells and their monitoring in ATL.

Highlights

  • Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive leukemia/lymphoma which was first proposed as a new disease entity in 1977 [1,2]

  • There is a long clinical latency over 50 years and low incidence of ATL from human T lymphotropic virus type 1 (HTLV-1) carriers and a thousand of ATL patients die in Japan every year [3]

  • It was implied that aberrant cellular proteins such as p53, signal transducers and activators of transcription (STAT) and Bcl-xL were associated with the development of ATL (Figure 1)

Read more

Summary

Introduction

Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive leukemia/lymphoma which was first proposed as a new disease entity in 1977 [1,2]. It is indicated that ATL is an age-related disease involving genetic changes are prior to malignant transformation and monoclonal expansion of HTLV-1 infected cells. ATL cells constitutively activated the Janus kinase (JAK)-STAT pathway important for HTLV-1-induced immortalization and transformation mechanisms [12]. We observed JAK-STAT pathway activation in ATL cells without cytokine stimulation.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.